IPO registrations (S-1, F-1) · Registrants

Loxo Oncology, Inc.

SEC CIK
1581720 · filings on EDGAR ↗
Registration
Form S-1, first filed 2014-06-30, last 2014-07-30; 1 initial registration, 2 amendments
Outcome
Final prospectus filed 2014-08-01; declared effective 2014-07-31
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
281 TRESSER BOULEVARD, 9TH FLOOR, Stamford, CT 06901
EIN
46-2996673
EDGAR entity type
operating
Insiders and CEO pay
Loxo Oncology, Inc. on the corporate pages

Offering terms

Proposed price range
$12.00–$14.00 per share (S-1/A filed 2014-07-30)
Final price
$13.00 per share, within the range (424B4 filed 2014-08-01, an initial public offering)
Shares sold
5,261,538
Gross proceeds
$68,399,994 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol LOXO
Lead underwriters
Cowen; Stifel
Syndicate
Oppenheimer; JMP Securities

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 7

FiledFormWhat it isName as filedEDGAR
2014-06-30S-1S-1 (registration)Loxo Oncology, Inc.0001047469-14-005954 ↗
2014-07-21S-1/AS-1/A (amendment)Loxo Oncology, Inc.0001047469-14-006303 ↗
2014-07-30S-1/AS-1/A (amendment)Loxo Oncology, Inc.0001047469-14-006498 ↗
2014-07-31S-1MEFS-1MEF (added securities)Loxo Oncology, Inc.0001104659-14-055596 ↗
2014-07-31EFFECTEFFECT (declared effective)Loxo Oncology, Inc.9999999995-14-002342 ↗
2014-08-01424B4424B4 (final prospectus)Loxo Oncology, Inc.0001047469-14-006588 ↗
2015-08-11EFFECTEFFECT (declared effective)Loxo Oncology, Inc.9999999995-15-002256 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-07-30S-1/Aregistration statement$12.00–$14.004,384,615-Nasdaq LOXO4primary document; range, shares headline, cover names 4document ↗
2014-08-01424B4final prospectus$13.005,261,538$68,399,994Nasdaq LOXO4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ACCESS INDUSTRIES MANAGEMENT, LLCTenPercentOwner22014
AI Loxo Holdings LLCTenPercentOwner22014
AISLING CAPITAL III LPTenPercentOwner102014–2018
Aisling Capital Partners III LLCTenPercentOwner102014–2018
Aisling Capital Partners III LPTenPercentOwner102014–2018
AI Value Holdings, LLCTenPercentOwner22014
BARRETT M JAMESDirector,TenPercentOwner42014–2015
BARRIS PETER JTenPercentOwner22014
BASKETT FORESTTenPercentOwner22014
Bilenker Joshua H.Director,OfficerPresident & CEO262014–2019
Blavatnik LenTenPercentOwner22014
Bonita David PDirector; Director,TenPercentOwner102014–2017
DEERFIELD MANAGEMENT COTenPercentOwnerOther32014
Deerfield Mgmt L.P.TenPercentOwnerOther32014
Deerfield Special Situations Fund, L.P.TenPercentOwnerOther32014
Deerfield Special Situations International Master Fund, L.P.TenPercentOwnerOther32014
DRANT RYAN DTenPercentOwner22014
ELMS STEVEDirector,TenPercentOwner; TenPercentOwner182014–2019
Flaherty Keith T.Director172014–2019
Florence Anthony A. Jr.TenPercentOwner22014
Flynn James ETenPercentOwnerOther32014person page Fuzzy
GOLDSTEIN DOV A MDDirector,Officer,TenPercentOwner; Officer,TenPercentOwnerCFO and Treasurer62014–2015
ISALY SAMUEL DDirector; TenPercentOwner62014–2017
KERINS PATRICK JTenPercentOwner22014
KOLLURI KRISHNA KITTUTenPercentOwner22014person page Fuzzy
Low Jennifer A.OfficerChief Medical Officer; EVP, Development & Research22014
MOTT DAVID MTenPercentOwner22014
Moyer Mikel PaulOfficerChief Scientific Officer12014
Naider Avi Z.Director142014–2019
NEA 14 GP, LTDTenPercentOwner22014
NEA Partners 14, L.P.TenPercentOwner22014
New Enterprise Associates 14, L.P.TenPercentOwner22014
ORBIMED ADVISORS LLCDirector; TenPercentOwner62014–2017
OrbiMed Capital GP V LLCDirector; TenPercentOwner62014–2017
Purcell Dennis JTenPercentOwner102014–2018
SANDELL SCOTT DTenPercentOwner22014
SCHIFF ANDREW NTenPercentOwner102014–2018
Sonsini Peter W.TenPercentOwner22014
Viswanathan RaviTenPercentOwner22014
Weller Harry RTenPercentOwner22014
ARRAY BIOPHARMA INCTenPercentOwner42014
Deerfield International Master Fund, L.P.TenPercentOwnerOther12014
DEERFIELD PARTNERS, LPTenPercentOwnerOther12014
Kunkel Lori AnneDirector112014–2019
Fuhrman AlanDirector82015–2019
Burstein JenniferOfficerSenior VP of Finance; Vice President of Finance252015–2019
MAYLEBEN TIMOTHY MDirector92015–2019
Van Naarden JacobOfficerChief Business Officer; Chief Operating Officer242016–2019
Harr SteveDirector52016–2019
Nanda NishaOfficerChief Development Officer32019

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2014-05-12Loxo Oncology, Inc.Biotechnology$23,888,747$23,888,74771

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationLoxo Oncology, Inc.CTState business registriesname and state
Business registrationLOXO ONCOLOGY, INC.CTState business registriesname and state
Business registrationLOXO ONCOLOGY, INC.CTState business registriesEIN (EXACT, as the state registration reports it)
Form D issuerLoxo Oncology, Inc.CTForm D private offeringsCIK (EXACT)
Patent assigneeLoxo Oncology, Inc.CTPatents (USPTO)name and state
SEC filerLoxo Oncology, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerLoxo Oncology, Inc.CTTrademarks (USPTO)name and state
Person pageJames E FlynnPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther)
Person pageKrishna Kittu KolluriPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.